Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Susy Kotit"'
Autor:
Susy Kotit, Magdi H. Yacoub
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundRheumatic Heart Disease (RHD) remains a major cause of valvular heart disease related mortality and morbidity in low- and middle-income countries, with significant variation in characteristics and course of the disease across different regi
Externí odkaz:
https://doaj.org/article/de799bd8055e41c3851532d205cb344c
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 10, p e0009830 (2021)
BackgroundAs little is known about the prevalence and clinical progression of subclinical (latent) rheumatic heart disease (RHD) in sub-Saharan Africa, we report the results of a 5 year follow-up of a community based, echocardiographic study of the d
Externí odkaz:
https://doaj.org/article/1622997563904090b81f3aa37561152d
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Rheumatic heart disease (RHD) is the most common cause of acquired heart disease in children and young adults. It continues to be prevalent in many low- and middle-income countries where it causes significant morbidity and mortality. Following the 20
Externí odkaz:
https://doaj.org/article/daa40188d47f42d38ea8550d3f8629f2
Autor:
Susy Kotit
Publikováno v:
Global Cardiology Science and Practice. 2023
Study and results: The first-in-human in vivo CRISPR/Cas9 trial of TTR Gene editing by NTLA-2001 in patients with Transthyretin Amyloidosis and cardiomyopathy was designed to evaluate the safety, tolerability, efficacy, and pharmacokinetic and pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0aa27e71533fe33f2418cd5e829a5cbd
https://doi.org/10.21542/gcsp.2023.4
https://doi.org/10.21542/gcsp.2023.4
Autor:
Susy Kotit
Publikováno v:
Global Cardiology Science and Practice. 2023
Study and Results: The EMMY trial was conducted to assess the safety and efficacy of empagliflozin in patients with acute myocardial infarction (AMI). A total of 476 patients with AMI were randomly assigned to empagliflozin (10 mg) or matching placeb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb118bcb060027a6ad23258b3c32320e
https://doi.org/10.21542/gcsp.2023.5
https://doi.org/10.21542/gcsp.2023.5
Autor:
Susy Kotit
Publikováno v:
Global Cardiology Science and Practice. 2023
Study and Results: The INVICTUS trial was conducted to assess efficacy and safety of once-daily rivaroxaban compared with a dose-adjusted VKA for the prevention of cardiovascular events in patients with RHD-associated AF. A total of 4,531 patients (a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3105cc4036ec37499434ff8eae4fc670
https://doi.org/10.21542/gcsp.2023.6
https://doi.org/10.21542/gcsp.2023.6
Publikováno v:
European Journal of Medical Case Reports. :56-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7e72b2630ef38b2946937041c552a9e
https://doi.org/10.24911/ejmcr/173-1550967806
https://doi.org/10.24911/ejmcr/173-1550967806
Publikováno v:
Cardiology in the young. 32(1)
Introduction:The standard transcatheter technique to profile the patent ductus arteriosus requires arterial access through the femoral artery and is associated with arterial complications, longer fluoroscopic time, contrast volume, and longer hospita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a800af332534f494073376d43b23598b
https://pubmed.ncbi.nlm.nih.gov/33896438
https://pubmed.ncbi.nlm.nih.gov/33896438
Autor:
Magdi H. Yacoub, Susy Kotit
Publikováno v:
Global Cardiology Science & Practice
Pregnant women with heart disease are vulnerable to many adverse cardiovascular events (AE). AEs during and after pregnancy continue to be important causes of maternal mortality and morbidity worldwide, with huge variations in burden in different cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23dd10bc7a20b0c9199b4dcd6e36b36a
http://europepmc.org/articles/PMC8133785
http://europepmc.org/articles/PMC8133785
Publikováno v:
Global Cardiology Science & Practice
Emergency treatment for thrombosed mechanical valve prothesis during pregnancy is not uncommon in low- and middle-income countries. The presence of a mechanical valve continues to be an important cause of maternal morbidity and mortality. There is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64eecc83af528c8f0ce7c77b55c92bf3
http://europepmc.org/articles/PMC7868097
http://europepmc.org/articles/PMC7868097